Epidemiological and Clinical Features of Meningococcal Meningitis in Infants - China, 2006-2023
- PMID: 40376257
- PMCID: PMC12075485
- DOI: 10.46234/ccdcw2025.095
Epidemiological and Clinical Features of Meningococcal Meningitis in Infants - China, 2006-2023
Abstract
Introduction: Infants have the highest incidence of meningococcal meningitis (MM) among all age groups in China. Infants receive their first and second doses of serogroup A meningococcal polysaccharide vaccine at 6 and 9 months of age.
Methods: We extracted data on MM cases among 0-11-month-old children reported during 2006-2023 from the National Notifiable Diseases Registry System and the National Meningococcal Disease Surveillance System and conducted an epidemiological and clinical analysis.
Results: During the study period, 721 infant MM cases were reported. Incidence decreased from 7.31 cases per million to 2.74 per million, while the all-age incidence declined from 1.27 cases per million to 0.06 per million. Among 210 cases with serogrouping results, five serogroups (A, B, C, W, Y) and non-groupable strains were detected. Serogroup A cases decreased from 36.36% to 1.87% during the study period, while serogroup B increased from 14.55% to 67.29%. Fever, nausea, and/or vomiting were common symptoms across all serogroups. The frequencies of petechiae and/or purpura in serogroup A (73%) and C (92%) were substantially higher than in other serogroups. Among serogroup B cases, 26.42% developed petechiae and/or purpura, 26.42% exhibited neck stiffness, and 13.21% had positive Kernig's and/or Brudzinski's signs.
Conclusions: The incidence of MM in infants has significantly decreased but remains higher than incidence across all age groups. Serogroup B cases were the most common. Atypical symptoms in infant cases challenge timely diagnosis. We suggest eligible infants receive meningococcal vaccination timely, and the development of serogroup B meningococcal vaccines should be accelerated.
Keywords: Infants; Meningococcal meningitis; Serogroups.
Copyright © 2025 by Chinese Center for Disease Control and Prevention.
Conflict of interest statement
No conflicts of interest.
Figures
References
-
- Chinese Preventive Medicine Association Experts’ consensus on immunization with meningococcal vaccines in China. Chin J Epidemiology. 2019;40(2):123–8. doi: 10.3760/cma.j.issn.0254-6450.2019.02.001. - DOI
LinkOut - more resources
Full Text Sources